Relmada Therapeutics
RLMD46
$3.40arrow_drop_up3.97%$0.13
Penny Stock
RLMD46
$3.40
arrow_drop_up3.97%AI Deep-Learning Forecast (RLMD)
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Relmada Therapeutics (RLMD) Stocklytics Forecast
Keep an eye on Relmada Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the analyst price prediction for Relmada Therapeutics (RLMD) stock?
Analysts have set a target price of $41.57 for Relmada Therapeutics (RLMD), based on forecasts from 7 analysts. The predicted price range extends from a high of $81 to a low of $8. This represents a potential increase of up to 2.28K% and a decrease of 135.29% from the current price of $3.4. These forecasts are as of 2019 Dec 16.
help
What are the analyst ratings for Relmada Therapeutics (RLMD) stock?
Currently, there are no analyst ratings available for Relmada Therapeutics (RLMD), possibly due to insufficient coverage or recent updates.
help
What is the AI price prediction for Relmada Therapeutics (RLMD) stock?
At present, there is no AI or machine-learning-based price prediction available for Relmada Therapeutics (RLMD) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.